Your browser doesn't support javascript.
loading
Prognostic value of sequencing-based minimal residual disease detection in patients with multiple myeloma who underwent autologous stem-cell transplantation.
Takamatsu, H; Takezako, N; Zheng, J; Moorhead, M; Carlton, V E H; Kong, K A; Murata, R; Ito, S; Miyamoto, T; Yokoyama, K; Matsue, K; Sato, T; Kurokawa, T; Yagi, H; Terasaki, Y; Ohata, K; Matsumoto, M; Yoshida, T; Faham, M; Nakao, S.
Afiliação
  • Takamatsu H; Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa;. Electronic address: takamaz@staff.kanazawa-u.ac.jp.
  • Takezako N; Department of Hematology, National Hospital Organization Disaster Medical Center of Japan, Tachikawa, Japan.
  • Zheng J; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Moorhead M; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Carlton VEH; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Kong KA; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Murata R; Division of Internal Medicine, Keiju Kanazawa Hospital, Kanazawa.
  • Ito S; Department of Medical Oncology, Iwate Medical University School of Medicine, Morioka.
  • Miyamoto T; Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka.
  • Yokoyama K; Department of Hematology/Oncology, Tokai University Hachioji Hospital, Hachioji.
  • Matsue K; Division of Hematology/Oncology, Department of Medicine, Kameda Medical Center, Kamogawa.
  • Sato T; Department of Medical Oncology and Hematology, Sapporo Medical University School of Medicine, Sapporo.
  • Kurokawa T; Department of Hematology, Toyama Red Cross Hospital, Toyama.
  • Yagi H; Department of Hematology, Kinki University School of Medicine Nara Hospital, Ikoma, Nara.
  • Terasaki Y; Division of Internal Medicine, Toyama City Hospital, Toyama.
  • Ohata K; Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa.
  • Matsumoto M; Department of Hematology, National Hospital Organization Shibukawa Medical Center, Shibukawa.
  • Yoshida T; Department of Hematology, Shizuoka City Shimizu Hospital, Shizuoka, Japan.
  • Faham M; Adaptive Biotechnologies Corp., South San Francisco, USA.
  • Nakao S; Hematology/Respiratory Medicine, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa.
Ann Oncol ; 28(10): 2503-2510, 2017 Oct 01.
Article em En | MEDLINE | ID: mdl-28945825
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Transplante de Células-Tronco / Melfalan / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Medula Óssea / Transplante de Células-Tronco / Melfalan / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article